These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 7792888

  • 1. Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis.
    Morris RE, Huang X, Gregory CR, Billingham ME, Rowan R, Shorthouse R, Berry GJ.
    Transplant Proc; 1995 Jun; 27(3):2068-9. PubMed ID: 7792888
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Obliterative airway disease after heterotopic tracheal xenotransplantation in a concordant rodent model: pathogenesis and treatment.
    Reichenspurner H, Adams B, Soni V, Brazelton T, Shorthouse R, Reitz BA, Berry GJ, Morris RE.
    Transplant Proc; 1996 Apr; 28(2):729-30. PubMed ID: 8623368
    [No Abstract] [Full Text] [Related]

  • 5. Effects of leflunomide and cyclosporine on aortic allograft chronic rejection in the rat.
    MacDonald AS, Sabr K, MacAuley MA, McAlister VC, Bitter-Suermann H, Lee T.
    Transplant Proc; 1994 Dec; 26(6):3244-5. PubMed ID: 7998130
    [No Abstract] [Full Text] [Related]

  • 6. Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine.
    Williams JW, Xiao F, Foster P, Clardy C, McChesney L, Sankary H, Chong AS.
    Transplantation; 1994 Apr 27; 57(8):1223-31. PubMed ID: 8178350
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of graft coronary arteriosclerosis after heart transplantation.
    Soukiasian HJ, Czer LS, Wang HM, Luthringer D, Wang C, Kamlot A, Quartel A, Trento A.
    Am Surg; 2004 Oct 27; 70(10):833-40. PubMed ID: 15529833
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Transplant vasculopathy in rat heart transplantation: a morphologic chameleon determined by antigen-dependent and -independent factors.
    Schmid C, Heemann U, Azuma H, Tilney NL.
    Transplant Proc; 1995 Jun 27; 27(3):2077-9. PubMed ID: 7792891
    [No Abstract] [Full Text] [Related]

  • 13. Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection?
    Deuse T, Schrepfer S, Pelletier MP, Fischbein MP, Robbins RC, Reichenspurner H.
    Transplant Proc; 2007 Mar 27; 39(2):569-72. PubMed ID: 17362784
    [Abstract] [Full Text] [Related]

  • 14. Rapamycin reverses acute heart, kidney, and pancreas allograft rejection and prevents accelerated heart allograft rejection in the rat.
    Chen H, Wu J, Xu D, Luo H, Daloze P.
    Transplant Proc; 1993 Feb 27; 25(1 Pt 1):719-20. PubMed ID: 8438454
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients.
    Wasowska B, Wieder KJ, Hancock WW, Berse B, Binder J, Strom TB, Kupiec-Weglinski JW.
    Transplant Proc; 1995 Feb 27; 27(1):423-6. PubMed ID: 7879047
    [No Abstract] [Full Text] [Related]

  • 17. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation.
    Xiao F, Shen J, Chong A, Liu W, Foster P, Blinder HL, Sankary H, McChesney L, Mital D, Williams JW.
    Transplant Proc; 1996 Apr 27; 28(2):691-2. PubMed ID: 8623348
    [No Abstract] [Full Text] [Related]

  • 18. Donor pretreatment with rapamycin delays rejection following intestinal allotransplantation.
    He G, Zhong R, Zhang Z, Garcia B, Black R, Duff J, Grant D.
    Transplant Proc; 1992 Jun 27; 24(3):1178. PubMed ID: 1604577
    [No Abstract] [Full Text] [Related]

  • 19. Reversal of ongoing rejection of allografts by rapamycin.
    Chen HF, Wu JP, Luo HY, Daloze PM.
    Transplant Proc; 1991 Aug 27; 23(4):2241-2. PubMed ID: 1871859
    [No Abstract] [Full Text] [Related]

  • 20. Complete control of humoral and cell-mediated xenoreactions with the combination of leflunomide and cyclosporine.
    Chong AS, Shen J, Xiao F, Blinder L, Foster P, Sankary H, Williams JW.
    Transplant Proc; 1996 Apr 27; 28(2):684. PubMed ID: 8623344
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.